APAC Automated Breast Ultrasound System Market size is poised to surpass USD 1.6 billion by 2028, according to a latest forecast report by Graphical Research.
Rising number of initiatives for spreading breast cancer awareness will favor the industry growth. Countries across the region observe October as the National Breast Cancer Awareness Month. For example, The Pink Initiative, India works to spread consciousness about breast cancer and support women affected by the ailment through online forums. The program also educates women on the ways to minimize the risk of contracting the disease.
Many similar initiatives also aim to detect breast cancer at its early stage. This will not only reduce treatment costs, but also decrease the mortality rate. For instance, the Australian government launched the ‘BreastScreen Australia’ program that offers free breast screening to women aged between 50-74 years. Such programs will promote the usage of ABUS technologies.
However, there is a notable dearth of skilled professionals across the region. ABUS devices also require heavy investments, which can discourage medical professionals from purchasing them. There is also a lack of proper medical reimbursement policies.
The Automated Breast Volume Scanner (ABVS) segment will observe more than 15% CAGR through 2028. ABVS is an advanced tool that consists of different elements, such as 3D workstation, flexible arm, and touchscreen technology. It allows a physician to change the settings according to their patient’s breast size. It generates 3D images that can detect breast cancer in asymptomatic women. ABVS also overcomes the limitations of handheld ultrasound systems. The device can be used in combination with mammography systems, which will further enhance the accuracy of the diagnosis.
Browse detailed statistical insights from the report, “Asia Pacific Automated Breast Ultrasound Systems (ABUS) Market Forecast 2028 By Product (Automated Breast Ultrasound Systems, Automated Breast Volume Scanner), By End-Use (Hospitals, Diagnostic Imaging Centers), Research Report, Country Outlook (Japan, China, India, South Korea, Australia, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
The hospital end-users will reach USD 1 billion by 2028. ABUS devices are widely used across many multi-specialty hospitals in the region as they offer high efficiency and accuracy while screening dense breast tissues. For example, Hokuto Hospital in Japan has utilized QVCAD systems as an investigational device for detecting breast cancer in patients. Since many patients opt to get treated at hospitals due to the ease of access to a variety of cutting-edge technologies and treatments, the installation of ABUS will also rise.
India ABUS market will showcase impressive growth during the forecast timeline. The occurrence of breast cancer is rising at a worrying rate across the country. As per the National Center for Disease Information and Research, breast cancer is the leading cause of cancer in Indian women, accounting for 39.4% of total cancer cases. This has prompted the government to launch initiatives to spread breast cancer awareness.
The automated breast ultrasound system in APAC market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2017 to 2028, for the following segments:
Asia Pacific Market, By Product
- Automated Breast Ultrasound System (ABUS)
- Automated Breast Volume Scanner (ABVS)
Asia Pacific Market, By End-use
- Diagnostic Imaging Centers
The above information has been provided for the following countries:
- Asia Pacific
- South Korea